← Back to Screener
Lifecore Biomedical, Inc. Common Stock (LFCR)
Price$5.20
Favorite Metrics
Price vs S&P 500 (26W)-25.67%
Price vs S&P 500 (4W)23.82%
Market Capitalization$199.38M
All Metrics
P/CF (Annual)27.20x
Book Value / Share (Quarterly)$0.91
P/TBV (Annual)5.76x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-9.91%
Cash Flow / Share (Quarterly)$0.07
Price vs S&P 500 (YTD)-36.87%
Gross Margin (TTM)31.03%
Net Profit Margin (TTM)-24.61%
EPS (TTM)$-1.18
10-Day Avg Trading Volume0.43M
EPS Excl Extra (TTM)$-1.18
Revenue Growth (5Y)-15.13%
EPS (Annual)$-0.48
ROI (Annual)-10.18%
Gross Margin (Annual)31.37%
Net Profit Margin (5Y Avg)-40.52%
Cash / Share (Quarterly)$0.47
Revenue Growth QoQ (YoY)131.92%
ROA (Last FY)-7.74%
Revenue Growth TTM (YoY)36.20%
EBITD / Share (TTM)$-0.02
ROE (5Y Avg)-104.45%
Operating Margin (TTM)-4.21%
Cash Flow / Share (Annual)$0.10
P/B Ratio5.85x
P/B Ratio (Quarterly)9.00x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.82x
Net Interest Coverage (TTM)-0.13x
ROA (TTM)-18.58%
EV / EBITDA (TTM)22.35x
EPS Incl Extra (Annual)$-0.48
Current Ratio (Annual)3.49x
Quick Ratio (Quarterly)2.18x
3-Month Avg Trading Volume0.26M
52-Week Price Return-12.80%
EV / Free Cash Flow (Annual)89.25x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.87
P/S Ratio (Annual)2.64x
Asset Turnover (Annual)0.33x
52-Week High$8.98
Operating Margin (5Y Avg)-19.38%
EPS Excl Extra (Annual)$-0.48
CapEx CAGR (5Y)-31.08%
Tangible BV CAGR (5Y)-35.73%
26-Week Price Return-21.69%
Quick Ratio (Annual)2.18x
13-Week Price Return-29.12%
Total Debt / Equity (Annual)4.18x
Current Ratio (Quarterly)3.49x
Enterprise Value$324.328
Revenue / Share Growth (5Y)-19.16%
Asset Turnover (TTM)0.75x
Book Value / Share Growth (5Y)-32.61%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.45x
Pretax Margin (Annual)-23.34%
Cash / Share (Annual)$0.47
3-Month Return Std Dev81.69%
Gross Margin (5Y Avg)29.90%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-28.49%
EBITDA Interim CAGR (5Y)-34.51%
ROE (Last FY)-52.73%
Net Interest Coverage (Annual)-0.31x
EPS Basic Excl Extra (Annual)$-0.48
P/FCF (TTM)28.96x
Receivables Turnover (TTM)5.56x
EV / Free Cash Flow (TTM)123.41x
Total Debt / Equity (Quarterly)4.18x
EPS Incl Extra (TTM)$-1.18
Receivables Turnover (Annual)3.86x
ROI (TTM)-25.21%
P/S Ratio (TTM)1.12x
Pretax Margin (5Y Avg)-29.05%
Revenue / Share (Annual)$2.02
Tangible BV / Share (Annual)$1.17
Price vs S&P 500 (52W)-42.63%
Year-to-Date Return-34.23%
5-Day Price Return13.98%
EPS Normalized (Annual)$-0.48
ROA (5Y Avg)-19.95%
Net Profit Margin (Annual)-23.78%
Month-to-Date Return44.62%
Cash Flow / Share (TTM)$-1.85
EBITD / Share (Annual)$0.09
Operating Margin (Annual)-0.97%
LT Debt / Equity (Annual)3.98x
P/CF (TTM)14.37x
ROI (5Y Avg)-29.14%
LT Debt / Equity (Quarterly)3.98x
EPS Basic Excl Extra (TTM)$-1.18
P/TBV (Quarterly)8.46x
P/B Ratio (Annual)9.00x
Inventory Turnover (TTM)3.60x
Pretax Margin (TTM)-24.22%
Book Value / Share (Annual)$0.91
Price vs S&P 500 (13W)-29.80%
Beta1.13x
P/FCF (Annual)54.87x
Revenue / Share (TTM)$4.77
ROE (TTM)-105.89%
52-Week Low$3.63
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.91
3.91
3.91
4.09
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
LFCRLifecore Biomedical, Inc. Common Stock | 1.12x | 36.20% | 31.03% | — | $5.20 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Lifecore Biomedical is a fully integrated CDMO providing development, manufacturing, and fill-finish services for complex sterile injectable pharmaceuticals. The company serves multiple delivery formats—syringes, vials, and cartridges—and operates two business segments: contract development and manufacturing services, and hyaluronic acid manufacturing.